Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants

Cho, Hye‐Kyung; Park, Su Eun; Kim, Yae-Jean; Jo, Dae Sun; Kim, Yun-Kyung; Eun, Byung Wook; Lee, Taekjin; Lee, Jina; Lee, Hyunju; Kim, Ki Hwan; Cho, Eun Young; Ahn, Jong Gyun; Choi, Eun Hwa

doi:10.3345/cep.2021.00507

Cited by 4 publications

(3 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…DTaP-IPV-Hib-HepB combination vaccine (Sanofi Pasteur) was approved in Korea on April 6, 2020, but has not yet been introduced into the NIP [19] . Many countries including the United States, United Kingdom, Australia, and Canada, have already introduced the DTaP-IPV-Hib-HepB combination vaccine into their NIPs based on its high safety and immunogenicity profile [20] .…”

Section: Discussionmentioning

confidence: 99%

Changes in vaccination practices among infants after the introduction of DTaP-IPV/Hib combination vaccines

Kim,

Park,

Jeong

et al. 2024

Vaccine: X

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Changes in vaccination practices among infants after the introduction of DTaP-IPV/Hib combination vaccines

Kim,

Park,

Jeong

et al. 2024

Vaccine: X

View full text Add to dashboard Cite

“…For example, IPV-included combination vaccines, such as DTaP-IPV-Hib or DTaP-HepB-IPV-Hib could reduce injections, reduce vaccination clinic visits, and keep polio population immunity high. Both combination vaccines are in use globally and are producing good results, for example, nearly 100% trial enrollees achieved seroprotection against target antigens [ 52 , 53 ].…”

Section: Recommendationsmentioning

confidence: 99%

Promoting higher-valent pediatric combination vaccines in China: challenges and recommendations for action

Li,

Chen,

Asturias

et al. 2024

Infect Dis Poverty

View full text Add to dashboard Cite

Many countries have adopted higher-valent pediatric combination vaccines to simplify vaccination schedules and minimize health expenditures and social costs. However, China is conservative in the use of pediatric combination vaccines. By reviewing and synthesizing quantitative and qualitative data, in this commentary we identify gaps and challenges to combination vaccine use and make recommendations for promoting use of higher-valent pediatric combination vaccines in China. Challenges are in four dimensions: (1) legislation and regulation, (2) immunization schedule design, (3) vaccine awareness and price, and (4) research and development capacity. To optimize the use of combination vaccines to reduce vaccine-preventable disease burden, we make recommendations that address key challenges: (1) develop policies and regulations to strengthen enforcement of the Vaccine Administration Law and remove regulatory hurdles that hinder combination vaccine research and development, (2) establish an evidence-informed policy-making mechanism for combination vaccines, (3) resolve immunization schedule conflicts between monovalent and combination vaccines, and (4) implement effective interventions to increase vaccine awareness and reduce price. Graphical Abstract

show abstract

“…Učestalost lokalnih ili sistemskih nuspojava povezanih sa rutinskim vakcinacijama kod prevremeno rođene dece je ekvivalentna onoj kod donešene novorođenčadi, a razlika nije statistički značajna (P<0,05). (13) Meta-analiza Badurdeena i saradnika o BCG vakcinaciji kod prevremeno rođene dece i novorođenčadi s malom porođajnom težinom pokazala je da rana vakcinacija u odnosu na kasnu vakcinaciju ima sličnu sigurnost, imunogenost i rezultate kožnih testova na tuberkulin. (14) Stručna istraživanja su pokazala da je sigurnost vakcinacije, kao i pojava neželjenih reakcija kod prevremeno rođene dece ista kao i kod donešene dece, te kad se uzme u obzir rizik od infekcija kod prevremeno rođenih, taj rizik je manji ako se prevremeno rođeno dete vakciniše protiv zaraznih bolesti na vreme.…”

unclassified

Pravovremenost Vakcinacije Prevremeno Rođene Dece

Rožek Mitrović

2024

Prev Ped

View full text Add to dashboard Cite

Prevremeno rođena deca su značajna populacija sa aspekta javnog zdravlja, morbiditeta i mortaliteta te je preventivni rad i vakcinacija od velikog značaja. Prevremeno rođena deca imaju veći rizik za pojavu neonatalnih i infektivnih bolesti, zbog nezrelosti imunog sistema i slabog prenosa zaštitnih majčinih antitela. Mnoge infektivne bolesti mogu se sprečiti sprovođenjem vakcinacije. Međutim, najveći problem u zemlji i inostranstvu je neblagovremena i nepotpuna vakcinacija prevremeno rođene dece. Pregledom literaturnih podataka u ovom radu predstavljeni su načini i protokoli sprovođenja pravovremenosti vakcinacije prevremeno rođene dece, sa ciljem efikasne prevencije zaraznih bolesti.

show abstract

Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants

Abstract: Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants

Cited by 4 publications

References 25 publications

Changes in vaccination practices among infants after the introduction of DTaP-IPV/Hib combination vaccines

Changes in vaccination practices among infants after the introduction of DTaP-IPV/Hib combination vaccines

Promoting higher-valent pediatric combination vaccines in China: challenges and recommendations for action

Pravovremenost Vakcinacije Prevremeno Rođene Dece

Contact Info

Product

Resources

About